Ignite Creation Date:
2024-05-06 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03366077
Status:
COMPLETED
Last Update Posted:
2021-01-05
First Post:
2017-12-04
Brief Title:
Double-blinded Randomized Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection
Sponsor:
BioGaia AB
Organization:
BioGaia AB
Study Overview
Official Title:
A Double-blinded Randomized Placebo-controlled Parallel-group Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection UTI in Adult Women Recently Treated for UTI
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Urinary tract infections UTIs are the most common bacterial infections in women with about 50 of women experiencing at least one UTI in their lifetime
The main pharmacological treatments of cystitis usually involve the use of antibiotics in particular quinolones such as ciprofloxacin and levofloxacin fosfomycin second-generation and third-generation cephalosporins and b-lactam antibiotics associated with b-lactamase inhibitors
The main pharmacological treatments of cystitis usually involve the use of antibiotics in particular quinolones such as ciprofloxacin and levofloxacin fosfomycin second-generation and third-generation cephalosporins and b-lactam antibiotics associated with b-lactamase inhibitors
Detailed Description:
This is a double-blinded randomized placebo-controlled parallel-group study evaluating the effect of the probiotic on recurrent urinary tract infection UTI in adult women recently treated for UTI
Primary objective The primary objective is to evaluate the effect of oral supplementation with probiotic on the frequency of UTI during six months from start of intervention in adult women with recurrent UTI
Primary objective The primary objective is to evaluate the effect of oral supplementation with probiotic on the frequency of UTI during six months from start of intervention in adult women with recurrent UTI
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None